Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Treasury Shares (2022 - 2025)

Historic Treasury Shares for Autolus Therapeutics (AUTL) over the last 4 years, with Q3 2025 value amounting to $94375.0.

  • Autolus Therapeutics' Treasury Shares rose 16080.53% to $94375.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $94375.0, marking a year-over-year increase of 16080.53%. This contributed to the annual value of $32412.0 for FY2024, which is 7216.32% down from last year.
  • According to the latest figures from Q3 2025, Autolus Therapeutics' Treasury Shares is $94375.0, which was up 16080.53% from $16250.0 recorded in Q2 2025.
  • Autolus Therapeutics' 5-year Treasury Shares high stood at $403331.0 for Q4 2022, and its period low was $16250.0 during Q1 2025.
  • For the 4-year period, Autolus Therapeutics' Treasury Shares averaged around $89207.1, with its median value being $41905.0 (2024).
  • Per our database at Business Quant, Autolus Therapeutics' Treasury Shares plummeted by 7216.32% in 2024 and then skyrocketed by 16080.53% in 2025.
  • Autolus Therapeutics' Treasury Shares (Quarter) stood at $403331.0 in 2022, then plummeted by 71.13% to $116436.0 in 2023, then plummeted by 72.16% to $32412.0 in 2024, then skyrocketed by 191.17% to $94375.0 in 2025.
  • Its Treasury Shares stands at $94375.0 for Q3 2025, versus $16250.0 for Q2 2025 and $16250.0 for Q1 2025.